Financhill
Back

Alnylam Pharmaceuticals Stock Predictions

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
27

ALNY
Alnylam Pharmaceuticals

Last Price:
265.13
Seasonality Move:
13.19%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Alnylam Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 43.3% based on the past 20 years of stock performance.
  • Alnylam Pharmaceuticals has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Alnylam Pharmaceuticals Stock Undervalued?
    The current Alnylam Pharmaceuticals [ALNY] share price is $265.29. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Alnylam Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 43.3% based on the past 20 years of stock performance.

Alnylam Pharmaceuticals Stock Rating

Sell
27
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals overpriced?

  • Alnylam Pharmaceuticals has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Alnylam Pharmaceuticals Stock Price History

Is ALNY stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com

52-Week Data

52-Week High:
304.39
52-Week Low:
141.98

Prediction Charts

Market Cap:
34.22B
Price in USD:
265.29
Volume:
940.3K
Beta:
1.20

Technical Analysis

SMA50:
274.11
SMA100:
258.29
SMA200:
206.52
52-Wk Change:
58.52%

Stock Predictions

  • Is Alnylam Pharmaceuticals stock public?
    Yes, Alnylam Pharmaceuticals is a publicly traded company.
  • What is the Alnylam Pharmaceuticals stock quote today?
    The Alnylam Pharmaceuticals stock price is 265.29 USD today.
  • How to buy Alnylam Pharmaceuticals stock online?
    You can buy Alnylam Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 286.39 300.55 301.87 286.39
Oct-18 296.01 295.93 298.94 295.51
Oct-21 294.33 292.01 295.39 288.34
Oct-22 292.10 296.48 297.51 291.90
Oct-23 296.48 294.87 299.17 292.20
Oct-24 293.92 293.69 301.05 293.45
Oct-25 293.69 284.86 293.74 283.78
Oct-28 288.35 286.91 290.94 285.85
Oct-29 285.93 284.69 287.02 282.22
Oct-30 284.10 281.49 287.87 281.39
Oct-31 275.41 266.72 276.00 263.65
Nov-1 267.05 273.91 274.03 264.00
Nov-4 268.82 269.93 272.92 263.67
Nov-5 268.47 265.29 268.89 264.23

Alnylam Pharmaceuticals Earnings

Alnylam Pharmaceuticals Earnings Report: Per Share Alnylam Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Alnylam Pharmaceuticals Forecast Revenue Growth

Alnylam Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and an increase next year of $0.66 per share.

* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.